Curated News Stories

Hand-picked stories from across the web, curated for relevance and quality.

Sigyn Therapeutics Appoints Dr. Christoph Zaba to Scientific Advisory Board to Advance Cardiovascular Treatment Technology

Sigyn Therapeutics Appoints Dr. Christoph Zaba to Scientific Advisory Board to Advance Cardiovascular Treatment Technology

Sigyn Therapeutics strengthens its scientific leadership with the appointment of Dr. Christoph Zaba, whose expertise in extracorporeal therapies supports the development of Sigyn Therapy™, a novel dialysis-based treatment designed to address cardiovascular disease by reducing harmful lipoproteins and inflammatory molecules with broader accessibility than current apheresis methods.

Read full story